Annual Gross Profit
$428.43 M
+$199.74 M+87.34%
31 December 2023
Summary:
Intra-Cellular Therapies annual gross profit is currently $428.43 million, with the most recent change of +$199.74 million (+87.34%) on 31 December 2023. During the last 3 years, it has risen by +$407.79 million (+1976.13%). ITCI annual gross profit is now at all-time high.ITCI Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$159.85 M
+$9.93 M+6.63%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly gross profit is currently $159.85 million, with the most recent change of +$9.93 million (+6.63%) on 30 September 2024. Over the past year, it has increased by +$43.17 million (+37.00%). ITCI quarterly gross profit is now at all-time high.ITCI Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$565.52 M
+$43.17 M+8.27%
30 September 2024
Summary:
Intra-Cellular Therapies TTM gross profit is currently $565.52 million, with the most recent change of +$43.17 million (+8.27%) on 30 September 2024. Over the past year, it has increased by +$177.25 million (+45.65%). ITCI TTM gross profit is now at all-time high.ITCI TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +87.3% | +37.0% | +45.6% |
| 3 y3 years | +1976.1% | +715.4% | +812.7% |
| 5 y5 years | +100.0% | +100.0% | +100.0% |
ITCI Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1976.1% | at high | +715.4% | at high | +812.7% |
| 5 y | 5 years | at high | at high | at high | |||
| alltime | all time | at high | at high | at high |
Intra-Cellular Therapies Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $159.85 M(+6.6%) | $565.52 M(+8.3%) |
| June 2024 | - | $149.92 M(+11.1%) | $522.35 M(+9.9%) |
| Mar 2024 | - | $134.94 M(+11.7%) | $475.39 M(+11.0%) |
| Dec 2023 | $428.43 M(+87.3%) | $120.80 M(+3.5%) | $428.43 M(+10.3%) |
| Sept 2023 | - | $116.68 M(+13.3%) | $388.27 M(+15.0%) |
| June 2023 | - | $102.97 M(+17.0%) | $337.61 M(+18.4%) |
| Mar 2023 | - | $87.98 M(+9.1%) | $285.07 M(+24.7%) |
| Dec 2022 | $228.69 M(+210.4%) | $80.64 M(+22.2%) | $228.69 M(+33.7%) |
| Sept 2022 | - | $66.02 M(+30.9%) | $171.02 M(+37.2%) |
| June 2022 | - | $50.42 M(+59.6%) | $124.61 M(+36.7%) |
| Mar 2022 | - | $31.60 M(+37.5%) | $91.15 M(+23.7%) |
| Dec 2021 | $73.67 M | $22.98 M(+17.2%) | $73.67 M(+18.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $19.61 M(+15.5%) | $61.96 M(+26.0%) |
| June 2021 | - | $16.97 M(+20.1%) | $49.17 M(+44.8%) |
| Mar 2021 | - | $14.12 M(+25.4%) | $33.95 M(+64.5%) |
| Dec 2020 | $20.64 M(>+9900.0%) | $11.26 M(+65.3%) | $20.64 M(+120.2%) |
| Sept 2020 | - | $6.81 M(+289.9%) | $9.37 M(+266.1%) |
| June 2020 | - | $1.75 M(+114.9%) | $2.56 M(+214.9%) |
| Mar 2020 | - | $813.20 K(>+9900.0%) | $813.20 K(>+9900.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is Intra-Cellular Therapies annual gross profit?
- What is the all time high annual gross profit for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual gross profit year-on-year change?
- What is Intra-Cellular Therapies quarterly gross profit?
- What is the all time high quarterly gross profit for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly gross profit year-on-year change?
- What is Intra-Cellular Therapies TTM gross profit?
- What is the all time high TTM gross profit for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies TTM gross profit year-on-year change?
What is Intra-Cellular Therapies annual gross profit?
The current annual gross profit of ITCI is $428.43 M
What is the all time high annual gross profit for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual gross profit is $428.43 M
What is Intra-Cellular Therapies annual gross profit year-on-year change?
Over the past year, ITCI annual gross profit has changed by +$199.74 M (+87.34%)
What is Intra-Cellular Therapies quarterly gross profit?
The current quarterly gross profit of ITCI is $159.85 M
What is the all time high quarterly gross profit for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly gross profit is $159.85 M
What is Intra-Cellular Therapies quarterly gross profit year-on-year change?
Over the past year, ITCI quarterly gross profit has changed by +$43.17 M (+37.00%)
What is Intra-Cellular Therapies TTM gross profit?
The current TTM gross profit of ITCI is $565.52 M
What is the all time high TTM gross profit for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high TTM gross profit is $565.52 M
What is Intra-Cellular Therapies TTM gross profit year-on-year change?
Over the past year, ITCI TTM gross profit has changed by +$177.25 M (+45.65%)